[go: up one dir, main page]

MX14910A - 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion. - Google Patents

2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.

Info

Publication number
MX14910A
MX14910A MX1491089A MX1491089A MX14910A MX 14910 A MX14910 A MX 14910A MX 1491089 A MX1491089 A MX 1491089A MX 1491089 A MX1491089 A MX 1491089A MX 14910 A MX14910 A MX 14910A
Authority
MX
Mexico
Prior art keywords
dideoxi
difluoronucleosides
procedure
preparation
Prior art date
Application number
MX1491089A
Other languages
English (en)
Inventor
Larry Wayne Hertel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX14910A publication Critical patent/MX14910A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX1491089A 1988-02-16 1989-02-13 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion. MX14910A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15611688A 1988-02-16 1988-02-16

Publications (1)

Publication Number Publication Date
MX14910A true MX14910A (es) 1993-11-01

Family

ID=22558157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1491089A MX14910A (es) 1988-02-16 1989-02-13 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.

Country Status (16)

Country Link
EP (1) EP0329348B1 (es)
JP (1) JP3142128B2 (es)
KR (1) KR890013049A (es)
CN (1) CN1035117A (es)
AU (1) AU607840B2 (es)
CA (1) CA1312599C (es)
DE (1) DE68923387T2 (es)
DK (1) DK66389A (es)
ES (1) ES2075040T3 (es)
HU (1) HU203363B (es)
IL (1) IL89258A0 (es)
MX (1) MX14910A (es)
NZ (1) NZ227960A (es)
PH (1) PH25381A (es)
PT (1) PT89705B (es)
ZA (1) ZA891076B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
AU629988B2 (en) * 1989-10-11 1992-10-15 Merrell Dow Pharmaceuticals Inc. Inosine/guanosine derivatives as antineoplastic agents
CA2073063A1 (en) * 1989-11-06 1991-05-07 Jo Klaveness Nucleoside derivatives
WO1991010671A1 (en) * 1990-01-11 1991-07-25 Isis Pharmaceuticals, Inc. Compositions and methods for detecting and modulating rna activity and gene expression
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
CA2079796A1 (en) * 1990-04-04 1991-10-05 Jo Klaveness Nucleoside derivatives
ZA914894B (en) * 1990-07-02 1992-04-29 Squibb & Sons Inc Purinyl and pyrimidinyl tetrahydrofurans
US6262241B1 (en) 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
AU2003291726A1 (en) 2002-11-04 2004-06-07 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
EP2217247A4 (en) 2007-11-06 2011-12-28 Pharmaessentia Corp NEW PROCESS FOR SYNTHESIS OF BETA NUCLEOSIDES
US8129429B2 (en) 2008-01-11 2012-03-06 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
BRPI0911208B1 (pt) 2008-04-18 2021-05-25 Reata Pharmaceuticals, Inc Compostos moduladores inflamatórios antioxidantes, seu uso, e composição farmacêutica
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
LT2276493T (lt) 2008-04-18 2019-01-10 Reata Pharmaceuticals, Inc. Antioksidaciniai uždegimo moduliatoriai: oleanolio rūgšties dariniai su amino ir kitomis modifikacijomis c-17
NZ588711A (en) 2008-04-18 2012-10-26 Reata Pharmaceuticals Inc C-17 homologated oleanolic acid derivatives for treating cancer
JP6042527B2 (ja) 2012-04-04 2016-12-14 ハロザイム インコーポレイテッド 抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
IL84842A0 (en) * 1986-12-24 1988-06-30 Lilly Co Eli Immunoglobulin conjugates

Also Published As

Publication number Publication date
NZ227960A (en) 1990-11-27
JP3142128B2 (ja) 2001-03-07
PH25381A (en) 1991-06-03
DK66389A (da) 1989-08-17
EP0329348A3 (en) 1990-09-12
JPH01249797A (ja) 1989-10-05
EP0329348A2 (en) 1989-08-23
CA1312599C (en) 1993-01-12
KR890013049A (ko) 1989-09-21
DE68923387D1 (de) 1995-08-17
PT89705A (pt) 1989-10-04
HUT49366A (en) 1989-09-28
EP0329348B1 (en) 1995-07-12
HU203363B (en) 1991-07-29
IL89258A0 (en) 1989-09-10
ES2075040T3 (es) 1995-10-01
AU2992689A (en) 1989-08-17
CN1035117A (zh) 1989-08-30
ZA891076B (en) 1990-10-31
DE68923387T2 (de) 1996-01-25
DK66389D0 (da) 1989-02-13
AU607840B2 (en) 1991-03-14
PT89705B (pt) 1994-04-29

Similar Documents

Publication Publication Date Title
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX9845A (es) Propanaminas 3-ariloxi-3-substituidas y procedimiento para su preparacion.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX7372A (es) Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
NO893826D0 (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
IT1236969B (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone.
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
ES545701A0 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
DK388986D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
IT8821079A0 (it) Copoliestere termotropico, procedimento per la sua preparazione e sua utilizzazione.
MX17042A (es) (1) benzotiopirano (4,3-c)-pirazoles y procedimiento para su preparacion.
IT1213536B (it) 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione.